Cardiovascular magnetic resonance-guided diagnosis of cardiac affection in a Caucasian sarcoidosis population

Sarcoidosis Vasculitis and Diffuse Lung Diseases

Volumn 32, Issue 4, 2015, Pages 325-335

  Pizarro, Carmen ^a   Goebel, Andreas ^a   Dabir, Darius ^a   Hammerstingl, Christoph ^a   Pabst, Stefan ^a   Grohé, Christian ^b   Fimmers, Rolf ^a   Stoffel Wagner, Birgit ^a   Nickenig, Georg ^a   Schild, Hans ^a   Skowasch, Dirk ^a   Thomas, Daniel ^a  

^a UNIVERSITY HOSPITAL BONN   (Germany)

^b Evangelische Lungenklinik Berlin ^*  (Germany)

Author keywords

Cardiac sarcoidal involvement; Cardiovascular magnetic resonance imaging; Caucasian population; Histologically proven sarcoidosis

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; DIPEPTIDYL CARBOXYPEPTIDASE; GADOLINIUM PENTETATE; PREDNISONE; SOLUBLE INTERLEUKIN 2 RECEPTOR; TROPONIN I; CONTRAST MEDIUM;

ADULT; ARTICLE; CARDIOVASCULAR MAGNETIC RESONANCE; CAUCASIAN; DIASTOLIC DYSFUNCTION; ELECTROCARDIOGRAM; FEMALE; FORCED EXPIRATORY VOLUME; FORCED VITAL CAPACITY; HEART LEFT VENTRICLE EJECTION FRACTION; HOLTER MONITORING; HUMAN; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIODIAGNOSIS; SARCOIDOSIS; TRANSTHORACIC ECHOCARDIOGRAPHY; AGED; AMBULATORY ELECTROCARDIOGRAPHY; CARDIAC MUSCLE; CARDIOMYOPATHIES; COMPLICATION; DIAGNOSTIC ERROR; EPIDEMIOLOGY; ETHNOLOGY; GERMANY; LUNG FUNCTION TEST; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; PATHOLOGY; PREDICTIVE VALUE; PREVALENCE; REPRODUCIBILITY; SARCOIDOSIS, PULMONARY;

ADULT; AGED; CARDIOMYOPATHIES; CONTRAST MEDIA; DIAGNOSTIC ERRORS; ELECTROCARDIOGRAPHY, AMBULATORY; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GADOLINIUM DTPA; GERMANY; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MYOCARDIUM; PREDICTIVE VALUE OF TESTS; PREVALENCE; PROSPECTIVE STUDIES; REPRODUCIBILITY OF RESULTS; RESPIRATORY FUNCTION TESTS; SARCOIDOSIS, PULMONARY;

EID: 84983177984     PISSN: 11240490     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Iannuzzi MC, Rybicki BA, Teirstein AS. Sarcoidosis. N Engl J Med 2007; 357: 2153-65.
2. Rybicki BA, Major M, Popovich J Jr, Maliarik MJ, Iannuzzi MC. Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 1997; 145: 234-41.
3. Johns CJ, Michele TM. The clinical management of sarcoidosis. A 50-year experience at the Johns Hopkins Hospital. Medicine (Baltimore) 1999; 78: 65-111.
4. Silverman KJ, Hutchins GM, Bulkley BH. Cardiac sarcoid: a clinicopathologic study of 84 unselected patients with systemic sarcoidosis. Circulation 1978; 58: 1204-11.
5. Gideon NM, Mannino DM. Sarcoidosis mortality in the United States 1979-1991: an analysis of multiple-cause mortality data. Am J Med 1996; 100: 423-7.
6. Baughman RP1, Winget DB, Bowen EH, Lower EE. Predicting respiratory failure in sarcoidosis patients. Sarcoidosis Vasc Diffuse Lung Dis 1997; 14: 154-8.
7. Banba K, Kusano KF, Nakamura K, et al. Relationship between arrhythmogenesis and disease activity in cardiac sarcoidosis. Heart Rhythm 2007; 4: 1292-9.
8. Yazaki Y, Isobe M, Hiroe M et al; Central Japan Heart Study Group. Prognostic determinants of long-term survival in Japanese patients with cardiac sarcoidosis treated with prednisone. Am J Cardiol 2001; 88: 1006-10.
9. Patel MR, Cawley PJ, Heitner JF, et al. Detection of myocardial damage in patients with sarcoidosis. Circulation 2009; 120: 1969-77.
10. Marckmann P, Skov L, Rossen K, et al. Nephrogenic systemic fibrosis: suspected causative role of gadodiamide used for contrast-enhanced magnetic resonance imaging. J Am Soc Nephrol 2006; 17: 2359-62.
11. Soejima K, Yada H. The work-up and management of patients with apparent or subclinical cardiac sarcoidosis: with emphasis on the associated heart rhythm abnormalities. J Cardiovasc Electrophysiol 2009; 20: 578-83.
12. Costabel U, Skowasch D, Pabst S, et al. Cardiac sarcoidosis: diagnostic and therapeutic algorithms. Pneumologie 2014; 68: 124-32.
13. Cotes JE, Chinn DJ, Quanjer PH, Roca J, Yernault JC, Standardization of the measurement of transfer factor (diffusing capacity). Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official statement of the European Respiratory Society. Eur Respir J Suppl 1993; 16: 41-52.
14. Kramer CM, Barkhausen J, Flamm SD, Kim RJ, Nagel E; Society for Cardiovascular Magnetic Resonance Board of Trustees Task Force on Standardized Protocols. Standardized cardiovascular magnetic resonance imaging (CMR) protocols, society for cardiovascular magnetic resonance: board of trustees task force on standardized protocols. J Cardiovasc Magn Reson 2008; 10: 35.
15. Schulz-Menger J, Wassmuth R, Abdel-Aty H, et al. Patterns of myocardial inflammation and scarring in sarcoidosis as assessed by cardiovascular magnetic resonance. Heart 2006; 92: 399-400.
16. Cerqueira MD, Weissman NJ, Dilsizian V, et al; American Heart Association Writing Group on Myocardial Segmentation and Registration for Cardiac Imaging. Standardized myocardial segementation and nomenclature for tomographic imaging of the heart. Circulation 2002; 105: 539-42.
17. Vignaux O. Cardiac sarcoidosis: spectrum of MRI features. AJR 2005; 184: 249-54.
18. Smedema JP, Snoep G, van Kroonenburgh MP, et al. Evaluation of the accuracy of gadolinium-enhanced cardiovascular magnetic resonance in the diagnosis of cardiac sarcoidosis. J Am Coll Cardiol 2005; 45: 1683-90.
19. Hiraga H, Yuwai K, Hiroe M. Guideline for the Diagnosis of Cardiac Sarcoidosis: Study Report on Diffuse Pulmonary Diseases (in Japanese). Jpn Ministry Health Welfare 1993; 23-4.
20. Greulich S, Deluigi CC, Gloekler S, et al. CMR imaging predicts death and other adverse events in suspected cardiac sarcoidosis. JACC Cardiovasc Imaging 2013; 6: 501-511.
21. Shimada T, Shimada K, Sakane T, et al. Diagnosis of cardiac sarcoidosis and evaluation of the effects of steroid therapy by gadolinium- DTPA-enhanced magnetic resonance imaging. Am J Med 2001; 110: 520-7.
22. Ferreira VM, Piechnik SK, Robson MD, Neubauer S, Karamitsos TD. Myocardial Tissue Characterization by Magnetic Resonance Imaging: Novel Application of T1 and T2 Mapping. J Thorac Imaging 2014; 29: 147-54.
23. Crouser ED, Ono C, Tran T, He X, Raman SV. Improved detection of cardiac sarcoidosis using magnetic resonance with myocardial T2 mapping. Am J Respir Crit Care Med 2014; 189: 109-12.
24. Date T, Shinozaki T, Yamakawa M, et al. Elevated plasma brain natriuretic peptide level in cardiac sarcoidosis patients with preserved ejection fraction. Cardiology 2007; 107: 277-80.